• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Hain North America - Close Out Letter 12/6/11

  

Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
Southwest Region
 
 

Denver District Office
Bldg. 20-Denver Federal Center
P.O. Box 25087
6th  Avenue & Kipling Street
Denver, Colorado 80225-0087
Telephone: 303-236-3000
        FAX: 303-236-3551
 

December 6, 2011
 

Mr. John Carroll, Chief Executive Officer
Hain North America
50 South Service Rd.
Melville, NY 11747

Dear Mr. Carroll:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter, DEN-11-04 WL dated December 3, 2010. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,

/s/

LaTonya M. Mitchell
Denver District Director